AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer
Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well AZD2171 works in treating patients with locally
advanced unresectable or metastatic liver cancer. AZD2171 may stop the growth of tumor cells
by blocking some of the enzymes needed for cell growth and by blocking blood flow to the
tumor